News and Announcements
Tokenise invited to the 2019 UK FinTech Trade Mission to Mexico
- Published August 28, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Tokenise has been invited by the United Kingdom Department of International Trade to attend their trade mission to Mexico.
The trade mission to Mexico provides Tokenise with a unique opportunity to meet with key players in the Mexican market, including investors, innovators and regulators. Mike Kessler, Founder and CEO of Tokenise, will be presenting at the mission demonstrating how Tokenise can give access to a wider investor community and the SME sector in Latin America.
Tokenise’s strategic objective to create a global network of brokers and exchanges and Mexico is one of the key jurisdictions in this market.
About Tokenise
Tokenise provides an end-to-end capital markets solution using blockchain technology to tokenise securities (including; equities, bonds, funds, royalties, private equity, assets and securitisation vehicles), from primary issuance, secondary trading to clearing and settlement. Tokenise is creating a community for entities that are looking to raise money, and for investors looking to invest in these businesses.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
